Labcorp (LH)
(Delayed Data from NYSE)
$209.49 USD
+2.40 (1.16%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $209.57 +0.08 (0.04%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth C Momentum C VGM
Price, Consensus and EPS Surprise
LH 209.49 +2.40(1.16%)
Will LH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for LH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for LH
Align Technology (ALGN) Q2 Earnings Top Estimates
Here's How Labcorp (LH) is Placed Ahead of Q2 Earnings Release
LH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strength Seen in Henry Schein (HSIC): Can Its 5.4% Jump Turn into More Strength?
Implied Volatility Surging for Labcorp (LH) Stock Options
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Other News for LH
Labcorp, Quest among health firms to cite impact from CrowdStrike issue
LH September 20th Options Begin Trading
Enzo Biochem: Is This Time Finally Different?
NOWDiagnostics Secures $22.5 Million in Series B Funding
Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT), Praxis Precision Medicines (PRAX) and Laboratory (LH)